Skip to main content
Home / Current Neuropharmacology, Volume 5, Number 2
Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

More about this publication?
Volume 5, Number 2, 2007

Articles

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
pp. 73-80(8)
Authors: Ashton, John C.; Glass, Michelle

Favourites:
ADD

Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
pp. 81-97(17)
Author: Basavarajappa, Balapal S.

Favourites:
ADD

Parkinson's Disease: Genetics and Beyond
pp. 99-113(15)
Authors: Inamdar, N. N.; Arulmozhi, D. K.; Tandon, A.; Bodhankar, S. L.

Favourites:
ADD

Cell and Gene Therapies for Refractory Epilepsy
pp. 115-125(11)
Author: Boison, Detlev

Favourites:
ADD

Current Experimental Therapy for Alzheimer's Disease
pp. 127-134(8)
Authors: Chen, Sheng; Zhang, Xiao-Jie; Li, Liang; Le, Wei-Dong

Favourites:
ADD

The Neurobiological Bases for Development of Pharmacological Treatments of Aggressive Disorders
pp. 135-147(13)
Authors: Siegel, Allan; Bhatt, Suresh; Bhatt, Rekha; Zalcman, Steven S.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content